Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2012

01-03-2012 | Clinical Research

Omental Gene Expression of Adiponectin Correlates with Degree of Insulin Sensitivity Before and After Gastric Bypass Surgery

Authors: Jiegen Chen, Anna Spagnoli, Alfonso Torquati

Published in: Obesity Surgery | Issue 3/2012

Login to get access

Abstract

Background

Circulating adiponectin is known to correlate negatively with insulin resistance in patients with obesity and diabetes. The aim of this study was to assess the effect of gastric bypass (GB) surgery on adiponectin gene expression in subcutaneous and omental adipose tissues.

Methods

Adipose tissues and plasma were obtained from 25 subjects undergoing GB surgery, 15 non-obese subjects, and 12 subjects after GB surgery. Real-time quantitative reverse transcription polymerase chain reaction was used for analysis of the adipose tissues. Adiponectin expression was normalized for glyceraldehyde 3-phosphate dehydrogenase and expressed as percentage of subject-matched subcutaneous expression which was given an arbitrary value of 100%. Insulin resistance was assessed by the homeostatic model assessment (HOMA). Circulating adiponectin was assayed by ELISA.

Results

Omental adiponectin gene expression was fivefold higher in subjects after GB when compared with age-matched morbidly obese subjects before GB (P < 0.01). There were no statistical differences in omental adiponectin gene expression observed in subjects after GB and age-matched non-obese subjects. For the entire cohort of subjects, there was a significant negative correlation between omental adiponectin expression and insulin resistance expressed by HOMA values (r = −0.62, P < 0.001). Circulating adiponectin was significantly lower (P < 0.05) in the obese group than in the non-obese and post-GB groups.

Conclusions

Omental adiponectin gene expression significantly increases after GB surgery reaching levels equal to age-matched non-obese subjects. Omental adiponectin expression has a significant negative correlation with the insulin resistance status.
Literature
1.
Brancati FL, Whelton PK, Kuller LH, et al. Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol. 1996;6:67–73.PubMedCrossRef
2.
Folsom A, Rasmussen M, Chambless L, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care. 1999;22:1077–83.PubMedCrossRef
3.
Gabriely I, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes. 2002;51:2951–8.PubMedCrossRef
4.
Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49:883–8.PubMedCrossRef
5.
Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endo Rev. 2000;21:697–738.CrossRef
6.
Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci. 2003;24:276–83.PubMedCrossRef
7.
Bolinder J, Kager L, Ostman J, et al. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes. 1983;32:117–23.PubMedCrossRef
8.
McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses. 1999;52:465–77.PubMedCrossRef
9.
Itamar Raz RE, Cernea S, Shafrir E. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes/Metab Res Rev. 2005;21:3–14.CrossRef
10.
Frayn KN. Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc. 2005;64:7–13.PubMedCrossRef
11.
Lau DC, Dhillon B, Yan H, et al. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005;288:H2031–2041.PubMedCrossRef
12.
Alessi MC, Bastelica D, Morange P, et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes. 2000;49:1374–80.PubMedCrossRef
13.
Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–15.PubMedCrossRef
14.
Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111–9.PubMedCrossRef
15.
Liu YM, Lacorte JM, Viguerie N, et al. Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding. J Clin Endocrinol Metab. 2003;88:5881–6.PubMedCrossRef
16.
17.
Lin E, Phillips LS, Ziegler TR, et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes. 2007;56:735–42.PubMedCrossRef
18.
Winer J, Jung CK, Shackel I, et al. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999;270:41–9.PubMedCrossRef
19.
20.
Torquati A, Lutfi R, Abumrad N. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg. 2005;9:1112–6. discussion 7–8.PubMedCrossRef
21.
Torquati A, Wright K, Melvin W, et al. Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. J Am Coll Surg. 2007;204:776–82.PubMedCrossRef
22.
Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm. 1999;257:79–83.PubMedCrossRef
23.
Hulver MW, Saleh O, MacDonald KG, et al. Ethnic differences in adiponectin levels. Metab Clin Exp. 2004;53:1–3.PubMedCrossRef
24.
Manco M, Fernandez-Real JM, Equitani F, et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab. 2007;92:483–90.PubMedCrossRef
25.
Swarbrick MM, Austrheim-Smith IT, Stanhope KL, et al. Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery. Diabetologia. 2006;49:2552–8.PubMedCrossRef
26.
Drolet R, Belanger C, Fortier M, et al. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity, Silver Spring, MD. 2009;17:424–30.CrossRef
27.
Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol. 2003;285:E527–33.
28.
Arvidsson E, Viguerie N, Andersson I, et al. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes. 2004;53:1966–71.PubMedCrossRef
29.
Garaulet M, Viguerie N, Porubsky S, et al. Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance. J Clin Endocrinol Metab. 2004;89:756–60.PubMedCrossRef
30.
Viguerie N, Vidal H, Arner P, et al. Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia. 2005;48:123–31.PubMedCrossRef
31.
Coughlin CC, Finck BN, Eagon JC, et al. Effect of marked weight loss on adiponectin gene expression and plasma concentrations. Obesity, Silver Spring, MD. 2007;5:640–5.CrossRef
32.
Altinova AE, Toruner F, Bukan N, et al. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J. 2007;54:221–6.PubMedCrossRef
33.
Mojiminiyi OA, Abdella NA, Al Arouj M. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes. Int J Obesity. 2007;31:213–20. 2005.CrossRef
Metadata
Title
Omental Gene Expression of Adiponectin Correlates with Degree of Insulin Sensitivity Before and After Gastric Bypass Surgery
Authors
Jiegen Chen
Anna Spagnoli
Alfonso Torquati
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 3/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-011-0568-x

Other articles of this Issue 3/2012

Obesity Surgery 3/2012 Go to the issue

Clinical Research

Revisiting the Revised Master Questionnaire for the Psychological Evaluation of Bariatric Surgery Candidates

Clinical Research

Impaired Abdominal Skin Sensory Function in Morbid Obesity and After Bariatric Surgery

Clinical Research

Morbid Obesity in Women is Associated to a Lower Prevalence of Thyroid Nodules

Letter to the Editor

Letter to the Editor: Long-Term Experience with Duodenal Switch in Adolescents

Clinical Research

Early Improvement in Albuminuria in Non-diabetic Patients after Roux-en-Y Bariatric Surgery

Clinical Research

Fast-Track Laparoscopic Gastric Bypass Surgery: Outcomes and Lessons from a Bariatric Surgery Service in the United Kingdom